Clinical Trials in Atlanta

Showing 1761-1780 of 19,805 trials

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

NCT06627413

Study ITI-007-037 is a Phase 1b, open-label study to evaluate the safety, tolerability, and PK of lumateperone long-acting injectable (LAI) formulations after a single intramuscular injection in patients with stale schizophrenia or schizoaffective disorder.

Schizophrenia or Schizoaffective

Intra-Cellular Therapies, Inc.52 participantsStarted Aug 2024

Los Alamitos, California, United States • Atlanta, Georgia, United States • Decatur, Georgia, United States +1 more locations

RECRUITINGPhase 3< 1 mile

A Study of Dotinurad Versus Allopurinol in Participants With Gout

NCT07089875

The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with hyperuricemia associated with gout.

Gout

Crystalys Therapeutics500 participantsStarted Aug 2025

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Gilbert, Arizona, United States +92 more locations

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

A Study of Dotinurad Versus Allopurinol in Participants With Gout

Find Trials by Condition in Atlanta

An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia

A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

F15 Recharge Free Axonics SNM System Clinical Study

A Study of miRNA 371 in Patients With Germ Cell Tumors

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Pulse Oximetry Performance Comparison in Newborns

Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors